AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Up 109.3% in August

AquaBounty Technologies, Inc. (NASDAQ:AQBGet Free Report) was the recipient of a significant increase in short interest in the month of August. As of August 14th, there was short interest totaling 183,426 shares, an increase of 109.3% from the July 30th total of 87,636 shares. Currently, 3.6% of the shares of the stock are sold short. Based on an average trading volume of 2,836,488 shares, the short-interest ratio is presently 0.1 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised AquaBounty Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 12th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, AquaBounty Technologies presently has an average rating of “Sell”.

Get Our Latest Analysis on AquaBounty Technologies

Institutional Investors Weigh In On AquaBounty Technologies

Several hedge funds and other institutional investors have recently modified their holdings of AQB. Two Sigma Investments LP bought a new position in shares of AquaBounty Technologies during the 3rd quarter worth about $84,000. BlackRock Inc. acquired a new position in AquaBounty Technologies in the 2nd quarter valued at approximately $51,000. Finally, Renaissance Technologies LLC lifted its position in shares of AquaBounty Technologies by 311.9% in the 4th quarter. Renaissance Technologies LLC now owns 121,585 shares of the company’s stock worth $113,000 after acquiring an additional 92,065 shares during the period. Institutional investors and hedge funds own 8.92% of the company’s stock.

AquaBounty Technologies Stock Performance

AquaBounty Technologies stock opened at $1.25 on Friday. The firm has a market cap of $6.44 million, a PE ratio of -1.52 and a beta of 1.39. The firm’s 50 day moving average price is $1.10 and its two-hundred day moving average price is $1.00. AquaBounty Technologies has a twelve month low of $0.77 and a twelve month high of $2.95.

AquaBounty Technologies (NASDAQ:AQBGet Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported ($0.26) earnings per share for the quarter.

About AquaBounty Technologies

(Get Free Report)

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.

See Also

Receive News & Ratings for AquaBounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AquaBounty Technologies and related companies with MarketBeat.com's FREE daily email newsletter.